Metrics to compare | 7096 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship7096PeersSector | |
|---|---|---|---|---|
P/E Ratio | 42.2x | 13.9x | −0.5x | |
PEG Ratio | −0.70 | 0.17 | 0.00 | |
Price/Book | 2.4x | 1.8x | 2.6x | |
Price / LTM Sales | 2.3x | 0.5x | 3.1x | |
Upside (Analyst Target) | - | 14.1% | 54.0% | |
Fair Value Upside | Unlock | 29.7% | 6.5% | Unlock |
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of new cell-based treatments, and pharmaceuticals and medical devices. It also engages in cell contract management and transportation business; extraction, purification, processing, storage, testing and sales of biological tissue-derived components; and medical facility operation and management business. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.